- 全部删除
您的购物车当前为空
Gimsilumab (MORAb-022) 是一种靶向粒细胞巨噬细胞集落刺激因子的人源化单克隆抗体,可用于研究 COVID-19 引起的炎症和低氧血症。
Gimsilumab (MORAb-022) 是一种靶向粒细胞巨噬细胞集落刺激因子的人源化单克隆抗体,可用于研究 COVID-19 引起的炎症和低氧血症。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,180 | In stock | |
| 5 mg | ¥ 2,950 | In stock | |
| 10 mg | ¥ 4,360 | In stock | |
| 25 mg | ¥ 6,980 | In stock |
Gimsilumab 相关产品
| 产品描述 | Gimsilumab (MORAb-022) is a humanized monoclonal antibody targeting granulocyte macrophage colony-stimulating factor for the study of COVID-19-induced inflammation and hypoxemia. |
| 别名 | 瑾司鲁单抗, MORAb-022, KIN-1901 |
| 分子量 | 145.8 kDa |
| CAS No. | 1648796-29-5 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容